We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

1,253 hedge funds and large institutions have $38.2B invested in Edwards Lifesciences in 2025 Q3 according to their latest regulatory filings, with 113 funds opening new positions, 444 increasing their positions, 443 reducing their positions, and 106 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more first-time investments, than exits

New positions opened: 113 | Existing positions closed: 106

0% more repeat investments, than reductions

Existing positions increased: 444 | Existing positions reduced: 443

0% more funds holding in top 10

Funds holding in top 10: 10 → 10 (0)

0% less funds holding

Funds holding: 1,259 → 1,253 (-6)

3% less capital invested

Capital invested by funds: $39.4B → $38.2B (-$1.2B)

1.96% less ownership

Funds ownership: 85.71% → 83.75% (-2%)

13% less call options, than puts

Call options by funds: $295M | Put options by funds: $337M

Holders
1,253
Holders Change
-6
Holders Change %
-0.48%
% of All Funds
16.44%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
113
Increased
444
Reduced
443
Closed
106
Calls
$295M
Puts
$337M
Net Calls
-$42.4M
Net Calls Change
-$147M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$942M
2
UBS AM
UBS AM
Illinois
+$321M
3
Viking Global Investors
Viking Global Investors
Connecticut
+$240M
4
Jennison Associates
Jennison Associates
New York
+$179M
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$111M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$664M
2
Millennium Management
Millennium Management
New York
-$383M
3
Marshall Wace
Marshall Wace
United Kingdom
-$260M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$180M
5
JP Morgan Chase
JP Morgan Chase
New York
-$134M
Name Holding Trade Value Shares
Change 		Change in
Stake
WWA
1226
Wealth Watch Advisors
Colorado
$1.32K +$1.33K +17 New
CT
1227
Clearstead Trust
Maine
$1.25K -$625 -8 -33%
MSWA
1228
Marshall & Sterling Wealth Advisors
New York
$1.24K – – –
AFG
1229
Albion Financial Group
Utah
$1.17K – – –
PS
1230
PayPay Securities
Japan
$1.13K -$469 -6 -30%
RPA
1231
Redwood Park Advisors
California
$1.09K – – –
BIM
1232
Breakwater Investment Management
Washington
$1.09K +$469 +6 +75%
FNWA
1233
Financial Network Wealth Advisors
Utah
$1.01K – – –
DF
1234
Dunhill Financial
United Kingdom
$1K -$547 -7 -35%
VNA
1235
Valley National Advisers
Pennsylvania
$1K -$391 -5 -25%
HIA
1236
HFM Investment Advisors
New Jersey
$933 – – –
HC
1237
Hurley Capital
New York
$778 +$781 +10 New
JSAM
1238
J. Safra Asset Management
New York
$778 +$781 +10 New
CSC
1239
Caldwell Sutter Capital
California
$700 – – –
RWS
1240
Retirement Wealth Solutions
Wisconsin
$700 +$703 +9 New
M
1241
MOTCO
Texas
$544 – – –
NMG
1242
New Millennium Group
Utah
$544 – – –
ACM
1243
Anfield Capital Management
California
$467 +$469 +6 New
FC
1244
Financial Consulate
Maryland
$467 +$469 +6 New
SA
1245
Seneschal Advisors
Washington
$467 +$469 +6 New
DF
1246
DecisionPoint Financial
Arizona
$458 – – –
BHWM
1247
Beaird Harris Wealth Management
Texas
$424 +$391 +5 New
DCM
1248
Davis Capital Management
Florida
$389 +$391 +5 New
EFMH
1249
E Fund Management (HK)
Hong Kong
$311 +$313 +4 New
IAS
1250
IMA Advisory Services
Colorado
$233 – – –
48 49
50
51 52

EW Hedge Fund Activity: Q3 2025 in Review

1,253 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q3 2025, worth a combined $38.2B — down 3% from $39.4B a quarter earlier.

Buyers outnumbered sellers: 113 funds opened new EW positions and 106 closed out — a net gain of 7 holders — while 444 added to existing stakes and 443 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $942M. The largest seller was Citadel Advisors, cutting an estimated $664M.

  • 1,253 institutional investors held Edwards Lifesciences (EW) as of Q3 2025, down from 1,259 in Q2 2025.
  • Funds reported $38.2B of Edwards Lifesciences stock for Q3 2025, down 3% quarter-over-quarter.
  • 113 funds opened new Edwards Lifesciences positions in Q3 2025 and 106 closed out, a net change of +7 holders.
  • The largest Edwards Lifesciences buyer in Q3 2025 was Fidelity Investments, an estimated $942M added.
  • The largest Edwards Lifesciences seller in Q3 2025 was Citadel Advisors, an estimated $664M sold.

Based on aggregated 13F filings for Q3 2025.